STATUTORY COMMUNICATIONS 2023 - 2024

Intimation of retirement of Mr. Milind Patil, Chief Financial Officer of the Company

Intimation regarding Appointment of Senior Management Personnel of the company

Intimation regarding resignation of Mr. Milind Patil as a Director from the Board

Pfizer Limited - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulation 30 - Transfer and assignment of Pfizer’s unexpired leasehold rights in MIDC Land to Zoetis Pharmaceutical Research Private Limited

Disclosure on Related Party Transactions as on September 30, 2023

Pfizer Limited – Change in Senior Management Personnel – 28.10.2023

Pfizer Limited – Appointment of Mr. P. Rengan as Executive Director – Plant Operations

Pfizer Limited – Notice for the Board Meeting – October 28, 2023

Pfizer Limited – Notice of closure for Trading Window – September 30, 2023

Intimation regarding resignation of Mr. Samir Kazi as the Executive Director – Legal of the Company

Appointment of Senior Management Personnel - 06.09.2023

Pfizer Limited 72nd AGM e-voting results

Pfizer Limited – Proceedings of the 72nd Annual General Meeting

Pfizer Limited – Change in Senior Management Personnel – 18.08.2023

Pfizer Limited – Notice for the Board Meeting – August 11, 2023

Important Communication for Shareholder

Pfizer Limited Annual Report and Notice of 72nd Annual General Meeting & Record Date

Pfizer Limited – Notice of closure for Trading Window – June 30, 2023

Pfizer Limited – Results of the Postal Ballot E-voting – May 29, 2023

Pfizer Limited – Stock Exchange intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015

Pfizer Limited – Notice for the Board Meeting – May 15, 2023

Pfizer Limited – Newspaper Advertisement - Notice of the Postal Ballot

Pfizer Limited – Notice of the Postal Ballot